Gould Robert J
SEC insider (Form 3/4/5 filer). CIK 0001577034. Director at Fulcrum Therapeutics, Inc. (FULC). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in CAMBRIDGE, MA.
Companies Gould Robert J has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Director
Gould Robert J
CIK: 0001577034
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Fulcrum Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 30, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Feb 2, 2026FULC
Fulcrum Therapeutics, Inc.
SaleDirect15K shares at avg. $10.72$161K - Jan 2, 2026FULC
Fulcrum Therapeutics, Inc.
SaleDirect15K shares at avg. $10.87$163K - Jan 2, 2026FULC
Fulcrum Therapeutics, Inc.
SaleDirect15K shares at avg. $11.87$178K - Nov 19, 2025FULC
Fulcrum Therapeutics, Inc.
SaleDirect15K shares at avg. $11.03$165K - Jun 26, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
36K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Feb 2, 2026 | FULC Fulcrum Therapeutics, Inc. | Sale | 15,000 | $10.72 | $160,857 | Direct |
| Jan 2, 2026 | FULC Fulcrum Therapeutics, Inc. | Sale | 15,000 | $10.87 | $163,089 | Direct |
| Jan 2, 2026 | FULC Fulcrum Therapeutics, Inc. | Sale | 15,000 | $11.87 | $178,089 | Direct |
| Nov 19, 2025 | FULC Fulcrum Therapeutics, Inc. | Sale | 15,000 | $11.03 | $165,495 | Direct |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 36,000 | - | - | Direct |
1-6 of 6 transactions